Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Laurus Labs Ltd

NSE: LAURUSLABS · BSE: 540222 · Pharmaceuticals & Biotechnology · 38 announcements

Share price
₹2,050.00
Market cap
₹1,10,764 Cr
Revenue (annual)
₹6,813 Cr
Net profit (annual)
₹888.8 Cr
P/E (TTM)
101.3×Sector 47.4×
Promoter holding
27.47%-0.02% QoQ
FII holding
28.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

22:08 IST NSE
Board Meeting Outcome

Laurus Labs Board Meeting Outcome

Laurus Labs Limited announced the appointment of Dr. Shekhar Chintamani Mande and Ms. Sutapa Banerjee as Independent Directors for five-year terms effective July 2026. Additionally, Mrs. Aruna Bhinge will complete her tenure as Director on July 6, 2026. These board changes bring extensive scientific and financial expertise to the company's leadership.

15:32 IST BSE
Board Meeting Outcome

Laurus Labs Board Meeting Outcome

Laurus Labs approved the appointment of Dr. Shekhar Chintamani Mande and Ms. Sutapa Banerjee as Independent Directors for five-year terms starting July 02, 2026. Additionally, Mrs. Aruna Bhinge will retire as an Independent Director on July 06, 2026, upon completing her second term.

18:55 IST NSE
Board Meeting Outcome

Laurus Labs Board Meeting Outcome

Laurus Labs Limited has scheduled a board meeting for April 30, 2026, to consider audited financial results for the year ended March 2026 and an interim dividend. The trading window for designated persons is closed from April 1, 2026, until May 2, 2026.

18:41 IST BSE
Board Meeting Outcome

Laurus Labs Board Meeting Outcome

Laurus Labs Ltd has scheduled a Board meeting on April 30, 2026, to approve audited financial results for FY26 and consider a second interim dividend. The company's trading window is closed from April 01 to May 02, 2026.